Novel benzamides, production thereof, and use thereof as medicaments

Details for Australian Patent Application No. 2009289378 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Wagner, Holger; Langkopf, Elke; Himmelsbach, Frank; Goeggel, Rolf; Jung, Birgit

Agent Spruson & Ferguson

Pub. Number AU-A-2009289378

PCT Pub. Number WO2010/026095

Priority 08163525.2 02.09.08 EP

Filing date 26 August 2009

Wipo publication date 11 March 2010

International Classifications

C07D 213/68 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/443 (2006.01)

A61K 31/4433 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/47 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/026095 Priority application(s): WO2010/026095

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009289379-7-(piperazine-1-ymethyl)-1H-indole-2-c arboxylic acid (phenyl)-amide derivatives and allied compounds as p38 MAP kinase inhibitors for the treatment of respiratory diseases

2009289367-Fire protection and/or fire fighting additives, associated compositions, and associated methods